Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019

NEXT STORY
Spring Bank Announces Positive Results from the Recently Completed Phase 2 Chronic Hepatitis B ACHIEVE Trial and Additional Inarigivir Studies
PREV STORY
DEINOVE invited to present at the 29th congress of the European Society of Clinical Microbiology and Infectious Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kura Oncology Reports Fourth Quarter and Full Year 2016 Operational and Financial Results

LA JOLLA, Calif., March 14, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (NASDAQ:KURA) a ...

author_avatar
NASDAQ Market News

Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer

WATERTOWN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader ...

author_avatar
NASDAQ Market News

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Second Quarter 2016 Results

CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical ...

author_avatar
NASDAQ Market News